Physician profile

Susan Ra

Dentist · Severna Park, MD

NPI 1225247315

$462.44

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$148.40
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$54.09

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Dentsply Sirona INC $148.40 2023 Cavitron, Suresmile
Sonendo INC $139.68 2022
Straumann USA LLC $60.75 2019
Septodont INC. $54.09 2024 Bioroot Flow- 2 G
Kerr Corporation $18.86 2022
Zimvie INC. $14.18 2022
Align Technology, INC. $14.17 2022
Voco America INC. $12.31 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Susan Ra

$462.44

in general payments reported 2019-2025

Years
2019-2024
Top company
Dentsply Sirona INC

https://glasscript.com/doctor/327565/susan-ra

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.